Evidence map›Paper›PMID 20382030›Full record

ArticleTrends in endocrinology and metabolism: TEM2010

Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis.

Melissa L Brown, Alan L Schneyer

Abstract read
In one paragraph

Article in Trends in endocrinology and metabolism: TEM, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The role of hepatokines in NAFLD.Cell metabolism · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Transgenerational effects of maternal bisphenol: a exposure on offspring metabolic health.Journal of developmental origins of health and disease · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Melissa L BrownPioneer Valley Life Science Institute, University of Massachusetts Amherst, Springfield, MA 01107, USA.
Alan L Schneyer
Pioneer (United States) · US

Funding

Physiologic Roles of Activin and Myostatin AntagonistsR01DK075058 · NIDDK · UNIVERSITY OF MASSACHUSETTS AMHERST · PI SCHNEYER, ALAN L · 2007 to 2010
$774k
NIDDK NIH HHS R01 DK075058NIDDK NIH HHS R01DK075058
6 · The paper itself

Abstract

Loss of functional beta-cells is the primary cause of type 2 diabetes, so that there is an acute need to understand how beta-cell number and function are regulated in the adult under normal physiological conditions. Recent studies suggest that members of the transforming growth factor (TGF)-beta family regulate beta-cell function and glucose homeostasis. These factors are also likely to influence beta-cell proliferation and/or the incorporation of new beta-cells from progenitors in adults. Soluble TGFbeta antagonists also appear to have important roles in maintaining homeostasis, and the coordinated activity of TGFbeta family members is likely to regulate the differentiation and function of adult beta-cells, raising the possibility of developing new diabetes therapies based on TGFbeta agonists or antagonists.

Indexed as

AnimalsDiabetes Mellitus, Type 2GlucoseHomeostasisInsulin-Secreting CellsMiceSignal TransductionTransforming Growth Factor betaGlucoseTransforming Growth Factor beta

Identifiers

PMID20382030
PMCPMC2897975
OpenAlexW2047791249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.